Delek US Holdings, Inc. filings document the formal reporting record for a downstream energy company with refining, logistics, pipeline, and renewable-fuels assets. Form 8-K disclosures cover operating and financial results, quarterly dividends, material agreements, credit-facility amendments, capital-structure changes, and executive leadership matters.
Proxy and annual-meeting filings describe board elections, executive compensation votes, the 2026 Long-Term Incentive Plan, auditor ratification, and shareholder voting results. The filings also identify Delek US common stock on the New York Stock Exchange and record its relationship with Delek Logistics Partners, LP, including general partner and majority limited partner interests.
Ion Asset Management Ltd. filed Amendment No. 2 to Schedule 13G reporting its beneficial ownership of Delek US Holdings, Inc. (DK) common stock. The firm reported 1,845,000 shares, representing 3.07% of the class, as of 09/30/2025.
Ion Asset Management has sole voting power and sole dispositive power over 1,845,000 shares, with no shared voting or dispositive power. The filer certified the holdings were not acquired to change or influence control of the issuer. This filing indicates a passive stake below 5%.
Delek US Holdings (DK) received a Schedule 13G from Ion Asset Management Ltd., disclosing beneficial ownership of 3,258,371 shares of Common Stock, representing 5.05% of the class as of October 24, 2024. Ion reports sole voting and sole dispositive power over these shares and certifies the holdings were not acquired to change or influence control. The filer re-submitted the statement under the correct issuer CIK after initially filing under an incorrect CIK; the dates remain the same.
Delek US Holdings (DK) reported an insider transaction by its EVP, Special Projects. On 11/11/2025, the officer sold 17,000 shares of common stock at a weighted average price of $41.42 and 10,000 shares at a weighted average price of $41.25. Following these sales, the reporting person beneficially owns 23,020 shares, held directly.
The filing notes the trades were executed under a Rule 10b5-1 trading plan adopted on March 6, 2025 and amended August 13, 2025. Price ranges were disclosed: $41.39–$41.59 for the first set and $41.16–$41.37 for the second.
Delek US Holdings (DK) reported insider activity by EVP Joseph Israel. On 11/11/2025, he sold 20,028 shares of common stock at a weighted average price of $41.115 (range: $40.935–$41.26). The same day, 2,652 shares were withheld for taxes upon equity award vesting at $41.70. On 11/12/2025, he sold an additional 4,380 shares at a weighted average price of $40.942 (range: $40.60–$41.11).
Following these transactions, Israel directly beneficially owned 55,761 shares.
Delek US Holdings (DK): EVP insider sale reported. An executive vice president sold 5,643 shares of common stock on 11/11/2025 at a weighted average price of $41.462, with trades ranging from $41.45 to $41.51, leaving 41,269 shares directly owned after this transaction. On 11/12/2025, the EVP sold an additional 2,303 shares at a weighted average price of $40.427, with trades ranging from $40.37 to $40.48, resulting in 38,966 shares directly owned afterward.
Delek US Holdings (DK) reported an insider transaction on a Form 4. Director Ezra Uzi Yemin sold common stock on 11/07/2025 pursuant to a Rule 10b5-1 plan. Two sales were reported at a weighted average price of $43.09, reflecting multiple trades between $43.00 and $43.39 per share.
Following these transactions, beneficial ownership stands at 154,719.047 shares direct and 679,656 shares indirect held by Yemin Investments, LP.
Delek US Holdings (DK) filed a Form 144 indicating a proposed sale of 28,494 common shares. The filing lists an approximate sale date of 11/11/2025, an aggregate market value of $1,166,605.81, and identifies Merrill Lynch as broker, with trading on the NYSE.
The shares were acquired through the vesting of stock awards on multiple dates between 12/09/2023 and 11/11/2025, as shown in the acquisition table. This notice outlines an intention to sell under Rule 144 and includes the required representation regarding knowledge of material nonpublic information.
Goldman Sachs Group and Goldman Sachs & Co. LLC filed a Schedule 13G on Delek US Holdings (DK), reporting beneficial ownership of 3,171,695.56 shares, or 5.3% of the common stock, as of 09/30/2025. The filing lists shared voting power over 3,171,276.56 shares and shared dispositive power over 3,171,427.56 shares, with no sole voting or dispositive power.
The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Delek US Holdings. The 13G indicates a passive ownership position consistent with routine institutional reporting thresholds.
DK filed a Rule 144 notice for a proposed sale of common stock. The filing lists 2,303 shares to be sold on the NYSE through Fidelity Brokerage Services, with an aggregate market value of $93,103.66 and 60,051,553 shares outstanding. The approximate sale date is 11/12/2025.
The shares were acquired via the company’s Employee Stock Purchase Plan: 948 shares on 03/28/2024 (cash) and 1,355 shares on 03/31/2025 (cash). The notice includes the standard representation regarding the absence of undisclosed material adverse information.
DK filed a Form 144 notice for the proposed sale of 5,643 shares of Common Stock. The filing lists an aggregate market value of $233,972.32, with an approximate sale date of 11/11/2025. The shares are to be sold through Citigroup Global Markets Inc. on the NYSE. Shares outstanding are reported as 60,051,553.
The securities to be sold were acquired on 06/09/2025 as compensation from the issuer, in the same amount of 5,643 shares. The filing also notes a prior transaction in the last three months: Robert Wright sold 7,135 shares of Common Stock on 09/02/2025 for $208,659.51.